TruaceTracing the truth around AIThursday, August 27, 2026
Health·The Trace·Dual reading·Published 2026-08-27

machine learning prediction of synchronous liver metastasis in pancreatic cancer using CT radiomics and clinical features

Source article: Predicting Synchronous Liver Metastasis in Pancreatic Cancer Using CT Radiomics and Clinical Features: A Machine Learning Approach

Abstract: Rationale and objectives To address the challenge of preoperative prediction of synchronous liver metastasis (LM) in pancreatic cancer (PC), we developed and validated machine learning models integrating clinical and computed tomography (CT) radiomics features, and compared the performance and interpretability of linear (linear discriminant analysis [LDA]) versus nonlinear (multilayer perceptron [MLP]) architectures. Materials and methods This retrospective study enrolled 340 patients with pancreatic ductal aden…

TRV-2026-0907Peer-reviewedPermanent record — cite & verify
Trace impact reading

Contested: both sides are scored from claims and sources, not community votes.

P 70The P score combines the specificity and measured human impact of the grounded problem claim with the strength of this Trace’s cited sources.G 72The G score combines the specificity and measured human impact of the grounded gain claim with the strength of this Trace’s cited sources.
Predicting Synchronous Liver Metastasis in Pancreatic Cancer Using CT Radiomics and Clinical Features: A Machine Learning Approach

Tumors of the stomach by Stout, Arthur Purdy, 1885- Armed Forces Institute of Pathology (U.S.). Public domain

The quick read

In a retrospective study of 340 pancreatic ductal adenocarcinoma patients, investigators developed machine learning models combining CT radiomics and clinical predictors to predict synchronous liver metastasis preoperatively. In an independent validation cohort of 102 patients, the best linear model (LDA) reached AUC 0.828 and the nonlinear model (MLP) reached AUC 0.822, both showing good calibration with Hosmer-Lemeshow P values of 0.551 and 0.682.

The tool is framed not as a replacement for pathology but as decision support for indeterminate subcentimeter liver lesions on CT, where low-risk scores could support surveillance and spare biopsy and high-risk scores could prompt biopsy or neoadjuvant systemic therapy. Uncertainty remains about generalizability beyond this single retrospective cohort and about stability, as LDA dropped to AUC 0.50 in lymph-node-negative cases while MLP was more stable across subgroups.

Main points
  • Retrospective study of 340 patients with pancreatic ductal adenocarcinoma (190 with LM, 150 without) with independent validation cohort n=102.
  • Five radiomics features selected via mRMR and LASSO combined with independent clinical predictors age, CEA, and clinical N stage to build 26 models.
  • Validation AUC 0.828 for LDA and 0.822 for MLP with good calibration and high net clinical benefit on decision curve analysis.
Gain

Integrated machine learning models using CT radiomics and clinical predictors achieved accurate preoperative prediction of synchronous liver metastasis in pancreatic ductal adenocarcinoma in validation, intended to assist decisions on surveillance versus biopsy or neoadjuvant therapy for indeterminate subcentimeter CT-

Problem

The linear LDA model showed unstable performance and poor discrimination in lymph-node-negative and pancreatic head tumor subgroups despite overall validation AUC.

The rundown

Researchers built 26 models from 340 retrospective cases using five selected radiomics features plus age, CEA, and clinical N stage, then evaluated optimal LDA and MLP models in a 102-patient validation cohort with ROC, calibration, decision curve, and SHAP analysis.

SHAP analysis showed clinical N stage dominated the LDA model while CEA and radiomics features were more prominent in MLP, and Friedman's H-statistic identified five significant feature interactions; MLP maintained AUC 0.66-0.77 across subgroups while clinical nomogram alone reached AUC 0.788.

Sources

Reader signal

How should this claim be treated?

The debate